Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Oral Octreolin in Patients With Acromegaly Receiving Parenteral Somatostatin Analogs
2011-002912-10Phase 2Completed
- Sponsor
- Chiasma
- Start
- Jul 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of octreotide in acromegaly, sponsored by Chiasma. Primary endpoint: Insulin-like Growth Factor 1 (IGF-1) concentration at end of Core Treatment Period. Started Jul 2011; status: completed.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2011-002912-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002912-10.